ライフサイエンスコーパス: immune sera

1 WT DENV4 to neutralization by DENV3 primary immune sera.

2 d-type DH012 to neutralization by guinea pig immune sera.

3 f parasite Ags unless Ags were injected with immune sera.

4 d with recipients of the Ig-poor fraction of immune sera.

5 ed with granulocytic Ehrlichia (GE)-positive immune sera.

6 mory splenocytes with LCMV-immune B cells or immune sera.

7 ro cultured, host-derived, and tickborne) to immune sera.

8 hich allowed the comparison of preimmune and immune sera.

9 ciated with ApoE and could be neutralized by immune sera.

10 completely protected by the transference of immune sera.

11 ies would expand the neutralizing breadth of immune sera.

12 ortant for this cross protection mediated by immune sera.

13 absorption of LF-binding antibodies from EF immune sera.

14 doxically increased virion neutralization by immune sera.

15 e new antigens that we confirmed using human immune sera.

16 aive B-cell-deficient mice by inoculation of immune sera.

17 ensitive to neutralization than WT by pooled immune sera.

18 most predominantly recognized antigen by the immune sera.

19 is and bacterial agglutination with anti-CS4 immune sera.

20 t cellular cytotoxicity has been observed by immune sera.

21 dia trachomatis PorB sequence and polyclonal immune sera.

22 be achieved by intravenous injection of the immune sera.

23 In addition, ca. 7% of immune sera (12 of 175 sera) had significant amounts of

24 Immune sera administered intranasally were able to confe

25 B. burgdorferi-immune sera also induces clearance of B. burgdorferi N40

26 pA, two-dimensional immunoblot analysis with immune sera also revealed additional details of the anti

27 bility to resist the bactericidal effects of immune sera and also was observed to increase pathogen s

28 However, the evidence that immune sera and B cells were unable to control infection

29 absorption of EF-binding antibodies from LF immune sera and by column absorption of LF-binding antib

30 is (ADCP) activities, were present with both immune sera and isolated MAbs, confirming the induction

31 In the current study, both immune sera and monoclonal antibodies from vaccinated hu

32 13 also inhibited the GXM binding of GXM-TT immune sera and naturally occurring serum antibodies fro

33 za viruses and facilitate the development of immune sera and neutralizing monoclonal antibodies that

34 tope recognized by all the conjugate vaccine immune sera and strategies for assessing polyclonal Ab a

35 y of primary human and nonhuman primate DENV immune sera and that the hinge region both induces NAbs

36 In the presence of immune sera and upon infection, TRIM21 also activates a

37 potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent r

38 els somewhat better than the wild-type gp120 immune sera as a result of an increased elicitation of a

39 Administration of immune sera at 4 days after spirochete challenge aborted

40 y, the majority of neutralizing Abs in human immune sera bound to intact virions but not to the ectod

41 clones that reacted specifically with pooled immune sera but not with pooled sera obtained from the s

42 -PPS IgA or IgM antibodies were removed from immune sera by affinity chromatography.

43 pecific total IgG, IgG1, and IgG2c titers in immune sera by day 77, respectively, and induced balance

44 tigens were identified with C. psittaci B577-immune sera by solid-phase scanning of overlapping octap

45 However, the protective capacity of immune sera cannot be predicted by measuring total anti-

46 odominant and was consistently recognized by immune sera collected at various times during the course

47 y analyses suggested stronger potency of V10 immune sera compared with LcrV in the passive transfer o

48 was significantly delayed in mice receiving immune sera, compared with saline or uninfected serum co

49 Absorption with the immunogen depleted the immune sera completely of anti-Golgi complex Ab (inducib

50 Passive transfer of these immune sera conferred complete protection from death upo

51 lack B lymphocytes and adoptive transfer of immune sera conferred partial protection to naive mice.

52 e observed transmission-blocking activity of immune sera correlated with antibody levels measured by

53 Importantly, none of the immune sera cross-reacted with human tissues.

54 Immunoblot analysis of prechallenge immune sera demonstrated that IL-12 treatment was associ

55 Immune sera depleted of anti-peptide Ab immunoprecipitat

56 The mCHO gp120 immune sera did not neutralize primary viruses to any si

57 Immune sera did not protect mice from tickborne spiroche

58 However, immune sera elicited by either immunogen were only weakl

59 like wild-type gp120 immune sera, GDMR gp120 immune sera failed to neutralize HXBc2, a T-cell line ad

60 However, immune sera failed to react with the recombinant on immu

61 ies (against unknown target antigens) within immune sera from actively infected mice.

62 Immune sera from animals infected with Anaplasma ovis, E

63 On a 7,455 peptide Pf proteome array, immune sera from at least 5 out of 9 group III vaccinees

64 an anti-BAD1 monoclonal antibody (MAb) or in immune sera from blastomycosis patients.

65 Immune sera from CSC-vaccinated hosts contained high lev

66 the reactivities of anti-rLcrV and anti-rV10 immune sera from cynomolgus macaques, BALB/c mice, and b

67 Immune sera from DNA-injected animals had antibodies to

68 Immune sera from guinea pigs immunized with recombinant

69 the chaotropic reagent Urea and probing with immune sera from healthy individuals (n = 109) increased

70 Comparatively, immune sera from IFN-gko mice showed a dramatic reductio

71 Immune sera from IL-10(-/-) and wild-type mice also exhi

72 Immune sera from IL-4(-/-) mice showed a dramatic increa

73 Immune sera from infected mice were therefore used to sc

74 icited a specific IgG response to PI Ag, and immune sera from m1E41920-KLH-immunized mice was able to

75 Immune sera from mice immunized with M2 VLP supplemented

76 Immune sera from mice infected with the Lyme disease spi

77 The immune sera from mice or guinea pigs contained high tite

78 s evident in long term infection studies and immune sera from MyD88-deficient mice were able to prote

79 Pf12 is strongly recognized by immune sera from naturally infected patients.

80 Immune sera from nonhuman primates immunized with a Pfs2

81 Immune sera from orally immunized mice conferred passive

82 Furthermore, using human immune sera from pandemic A/California/04/2009 immune su

83 gM was the major detectable antibody (Ab) in immune sera from PIV-vaccinated CD4(+) T cell-deficient

84 cell-deficient mice, and passive transfer of immune sera from PIV-vaccinated CD4(+) T cell-deficient

85 Immune sera from rabbits, sera from chronically infected

86 700 proteins was constructed and probed with immune sera from Salmonella-infected mice and humans.

87 neutralization by soluble CD4 (sCD4), pooled immune sera from SIV239-infected rhesus macaques, and mo

88 Immune sera from the anti-hFcgammaRI-PspA-immunized Tg m

89 gous Env or challenge strain-specific Env in immune sera from the vaccinated ponies did not correlate

90 ity, and CDC activity of a panel of mAbs and immune sera from these trials on the same two tumor cell

91 Unlike wild-type gp120 immune sera, GDMR gp120 immune sera failed to neutralize

92 cation is increased rather than decreased by immune sera, has been observed in vitro for a large numb

93 ports of enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previ

94 2-type cytokines and SRW-specific Abs in the immune sera in contrast to a direct Th2 response observe

95 vity in vitro, and passive transfer of these immune sera into B. burgdorferi-infected SCID mice cause

96 ptor bearing cells, we passively transferred immune sera into FcR gamma-chain knockout mice.

97 h LcrV-derived peptides, rV10, but not rLcrV immune sera, lacked antibodies recognizing linear LcrV o

98 specifically to MCA205 tumor cells, and such immune sera mediated tumor cell lysis in the presence of

99 In contrast, immune sera-mediated clearance of B. burgdorferi N40 is

100 Whole LF and EF immune sera neutralized LeTx and EdTx, respectively.

101 The administration of immune sera obtained from PUB1-TT-immunized mice earlier

102 All four are recognized by the immune sera of animals and humans vaccinated with TBV25H

103 proteins recognized by total IgG and IgG2 in immune sera of outer membrane-vaccinated cattle were det

104 Adoptive transfer of either immune sera or splenocytes mediated significant protecti

105 tantly, passive immunization with anti-Ftr1p immune sera protected DKA mice from infection with R. or

106 Passive transfer of immune sera protected mice when they were challenged wit

107 onstrated that immune cells, with or without immune sera, protected recipients from challenge with pa

108 Immune sera provided no protection when given with lymph

109 The efficacy of PUB1-TT-induced immune sera provides proof of principle that a mimotope-

110 Immune sera raised against intact mouse P. carinii recog

111 Antibody competition studies revealed that immune sera raised to high-molecular-weight Delta123 was

112 By contrast, the immune sera raised to monomeric Delta123 predominantly b

113 t PVM proteins under conditions in which AGM immune sera reacted strongly.

114 The immune sera reacted with cell surface CCR5 expressed on

115 More human immune sera reacted with this "K1-like Super Repeat" ant

116 Mouse rRo60 completely inhibited the immune sera reactivity to La, SmD, and 70-kDa U1RNP.

117 In addition, human immune sera recognize the Histoplasma Cfp4 protein, conf

118 Nonetheless, systemic administration of immune sera reduced bacterial numbers significantly in n

119 Previous studies of human dengue-immune sera reported that a significant proportion of an

120 observed, but in vitro analyses of the mouse immune sera revealed that the antiviral activity of the

121 Furthermore, these immune sera showed antiviral activities against a panel

122 were used to generate high-titer polyclonal immune sera that demonstrated HPV genotype-restricted re

123 h monoclonal antibodies and polyclonal human immune sera that neutralize the prototype strain.

124 d sera from human adults immunized with AVA (immune sera), the anthrax vaccine currently approved for

125 thermore, passive systemic administration of immune sera to FimH also resulted in reduced bladder col

126 oninhibitory and inhibitory high-titer human immune sera to identify target epitopes associated with

127 ow that the administration of B. burgdorferi-immune sera to IFN-gammaR-deficient mice that have been

128 was also observed after passive transfer of immune sera to infected SCID mice.

129 The ability of rabbit and monkey immune sera to neutralize prostaglandin E2 (PGE2) produc

130 ly invulnerable to the protective effects of immune sera, unlike spirochetes grown in vitro, which ar

131 Finally, when immune sera was ingested by mosquitoes through a membran

132 Recognition of NF54 PEs by immune sera was observed, suggesting P. falciparum eryth

133 The dominant protein recognized by the immune sera was purified by ion exchange chromatography

134 ting the site-specific antibodies in vaccine immune sera, we demonstrated that vaccination elicited f

135 Immune sera were also tested for functional activity by

136 Immune sera were assayed for the presence of type-specif

137 The immune sera were broadly opsonic and were bactericidal a

138 Rabbit immune sera were evaluated for their ability to kill Tx1

139 These immune sera were protective when administered to naive p

140 hically diverse CSA-binding isolates, rabbit immune sera were screened on four heterologous CSA-bindi

141 Pools of LF or EF immune sera were tested for reactivity to rLF or rEF by

142 in-killed Enterococcus faecalis strains, and immune sera were tested in an opsonophagocytic assay aga

143 ns that selectively and specifically bind to immune sera were then enriched using a multi-step pannin

144 Immune sera were then fractionated into Ig-rich and Ig-d

145 with syngeneic prostate homogenates, and the immune sera were used to screen prostate proteins for im

146 Immune sera with high titers of anti-Dr antibody inhibit

147 Immune sera with reactivity against different Abeta epit

148 Additionally, those immune sera with the highest oligomeric gp160 antibody b

149 Absorption of three different bovine immune sera with whole P. haemolytica cells resulted in

150 to in vitro neutralization by MV polyclonal immune sera without altering its thermostability.